Ann: Uscom and US Koneksa Extend Technology Partnership, page-4

Still seems early days on spirometers and ehealth but the big medical companies seem very aware of the potential for lung device product growth due to long covid - asthma etc.
I doubt it will help the bottom line at all as yet but it does state the agreement establishes a pathway for the Uscom device to become a standard lung function testing device.
The heard it all before reaction or no reaction is expected however still hoping one day the promises become reality .
Doesn’t seem a lot of selling down at these prices as most have already left as you mentioned and the rest like me see the under $20mill valuation as crazy with the medical product devices they sell however it’s not crazy until they produce the sales and revenue numbers and time for growth talk the company always feels it is about to achieve. The lack of buying concerns me more than the constant selling over the last 3 months.